Searched for
COHERUS BIOSCIENCES
Pharma & healthcare deals see shifting focus on scalable, global models: Grant Thornton BharatIndia's pharma and healthcare sector demonstrates resilient investor interest, marked by a 34% year-on-year increase in deal volumes and a ...- Biosimilar brand buy to help Intas Pharma take on biggiesIn one of the biggest deals worldwide for a biosimilar brand, Ahmedabad-based Intas agreed to buy Udenyca-the brand name for medication peg...
- Wall Street ekes out modest gains as S&P 500 hovers near all-time closing highU.S. stocks closed slightly higher in languid trading on Wednesday, with little market-moving news to fuel conviction as the S&P 500 hovere...
- US stocks rise, S&P 500 near all-time highThe benchmark index is within a whisker of breaching its record close touched in January 2022 and on track to post its biggest quarterly ga...
- Blow to Roche's cancer immunotherapy prospects as 2nd trial failsIn a study, a combination of tiragolumab and Roche's established Tecentriq drug did not slow disease progression in newly diagnosed cases o...
- Biocon puts arthritis drug on backburnerBiocon and Mylan have been working for a decade on a biosimilar version of the drug, originally sold by Amgen under brand name Enbrel.
Load More